Extracorporeal Focused Shock Wave Therapy for Primary Knee Osteoarthritis
Brazil30 participantsStarted 2016-05
Plain-language summary
The purpose of this study is to determine whether Extracorporeal Focused Shock Wave Therapy reduces knee pain and enhance function in patients with primary knee osteoarthritis.
Who can participate
Age range45 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Clinical and radiologic diagnosis of primary knee osteoarthritis (Kellgren \& Lawrence I, II or III);
* Capability to understand the Informed Consent Form;
* Chronic pain for at least 3 months prior to inclusion, measured by VAS. (VAS 4 or above);
* Absence of skin injures, infections or tumor in the target knee;
* Availability to comply with the visits.
Exclusion Criteria:
* History of spinal cord stenosis or clinical symptoms of lumbar radiculopathy;
* History or onset neurological diseases;
* Generalized pain or fibromyalgia;
* Inability to walk;
* History of knee surgery in the target knee;
* Secondary causes of osteoarthritis;
* Use of statins and quinolones in the previous year;
* Uncontrolled and ongoing psychiatric diseases;
* Invasive knee treatments with hyaluronic acid infusion, corticosteroids and anaesthetics, in the target knee, up to 6 months previous to study inclusion.